Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Milestone Pharmaceuticals Inc. (MIST) had Income from Continuous Operations of $-12.97M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-12.97M |
|
-- |
|
-- |
|
$12.53M |
|
$-12.53M |
|
$-0.43M |
|
$-12.97M |
|
$-12.97M |
|
$-12.97M |
|
|
Income from Continuous Operations |
$-12.97M |
$-12.97M |
|
$-12.97M |
|
$-12.53M |
|
$-12.53M |
|
66.38M |
|
66.38M |
|
$-0.20 |
|
$-0.20 |
|
| Balance Sheet Financials | |
$46.17M |
|
$0.16M |
|
$1.25M |
|
$47.42M |
|
$9.28M |
|
$55.24M |
|
$55.88M |
|
$65.16M |
|
$-17.75M |
|
$-17.75M |
|
$-17.75M |
|
53.49M |
|
| Cash Flow Statement Financials | |
$-26.52M |
|
$43.53M |
|
$0.18M |
|
$25.31M |
|
$42.50M |
|
$17.18M |
|
$2.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.97 |
|
-- |
|
-- |
|
1.47 |
|
-3.11 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
73.07% |
|
73.07% |
|
-27.34% |
|
-34.58% |
|
$-0.33 |
|
$-0.40 |
|
$-0.40 |
|